📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-12 18:49
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Shanthala FMCG Board Takes Final Forensic Audit Report on Record
Shanthala FMCG Products Limited informed the exchange that its Board of Directors met on October 12, 2026, to take on record the final forensic audit report. The report was issued by forensic auditor M/s. GuruJana Consulting LLP, Chartered Accountants. The company did not disclose the findings, scope, or financial implications of the audit report in the filing. Given the company's micro-cap size of Rs 9 Cr and TTM revenue of Rs 102 Cr, any forensic findings could carry significant corporate governance implications.
Confidence: MEDIUM
What changedThe Board of Directors received and formally took on record the final forensic audit report from GuruJana Consulting LLP.
Why it mattersA forensic audit typically indicates investigation into potential financial irregularities, compliance lapses, or accounting discrepancies, posing potential governance risks.
Meeting duration: 35 minutesMeeting date: October 12, 2026Audit findings disclosed: not disclosedMarket Cap: Rs 9 Cr
📅 Short termThe stock may face scrutiny and volatility as market participants await clarity on the audit findings and whether any financial restatements are required.
📈 Long termLong-term perception depends heavily on the nature of the forensic findings, governance remediation, and whether core operations or historical figures are impacted.
⚠ Risk flags
- Undisclosed forensic audit findings
- Potential corporate governance or accounting integrity concerns
Key Highlights
Board meeting held on October 12, 2026, from 03:30 PM to 04:05 PM (IST)
Final forensic audit report issued by M/s. GuruJana Consulting LLP (LLPIN: ACP-9378) taken on record
Findings and quantifiable impacts of the forensic audit were not disclosed in the filing
Company market capitalization stands at Rs 9 Cr against TTM revenue of Rs 102 Cr
👀 What to Watch
Track subsequent disclosures for the specific findings or executive summary of the forensic audit report, along with any regulatory commentary or management actions.
Shanthala FMCG Seeks 3-Month Extension for FY26 AGM Due to Ongoing Forensic Audit
Shanthala FMCG Products Limited has applied to the Registrar of Companies (ROC) seeking a three-month extension of time to hold its Annual General Meeting (AGM) for the financial year ended March 31, 2026. The delay is attributed to an ongoing forensic audit of the company's books of accounts, which prevents the finalization of FY26 financial statements until the audit report is received. The decision was approved by the Board via a circular resolution passed on September 08, 2026. This adds uncertainty to the micro-cap trading firm, which has a market cap of approximately Rs 11 Cr.
Confidence: HIGH
What changedShanthala FMCG has formally requested a 3-month deferral from the ROC for its FY26 AGM because an active forensic audit has stalled financial statement finalization.
Why it mattersAn ongoing forensic audit signals severe accounting or governance concerns, creating heightened risk around reported historical figures and potential regulatory scrutiny.
AGM Extension Period Sought: 3 monthsFinancial Year Affected: March 31, 2026Circular Resolution Date: September 08, 2026Market Capitalization: Rs 11 Cr
📅 Short termNegative sentiment is likely to persist or worsen as the market digests the uncertainty surrounding the forensic audit and delayed FY26 results.
📈 Long termThe outcome of the forensic audit poses significant structural and governance risks, potentially leading to restatements, financial penalties, or regulatory sanctions.
⚠ Risk flags
- Ongoing forensic audit of books of accounts
- Delayed finalization and filing of FY26 financial statements
- Risk of adverse findings, accounting restatements, or regulatory action
Key Highlights
Applied for a 3-month extension to hold the AGM for the FY ended March 31, 2026
Delay caused by an ongoing forensic audit of the company's books of accounts
Financial statements for FY26 pending finalization until forensic audit report is received
Board approval secured via circular resolution dated September 08, 2026
👀 What to Watch
Track the findings of the pending forensic audit report and look for the ROC's approval or rejection of the AGM extension request.
₹2.65 Lakh Fine and Forensic Audit: Shanthala FMCG Delays FY26 Results Over Accounting Gaps
Shanthala FMCG Products Limited has failed to submit its audited financial results for the year ended March 31, 2026, leading to an NSE fine of ₹2,65,500 as of July 16, 2026. The delay is due to 'material gaps and inconsistencies' identified by statutory auditors, which prompted the Board to appoint a Forensic Auditor. The company faces severe regulatory consequences, including the potential freezing of promoter holdings (61.91% stake) and a shift to the 'Z' category (Trade-for-Trade) if compliance is not met. The Board has resolved to pay the penalties and will seek a waiver only after the results are filed.
Confidence: HIGH
What changedThe company has transitioned from a routine reporting delay to a formal forensic investigation due to auditor-identified accounting discrepancies.
Why it mattersFor a micro-cap company with a market capitalization of only ₹12 Cr, a forensic audit and regulatory non-compliance signal significant governance risks and potential internal control failures.
Total Fine Payable (as of July 16): ₹2,65,500Daily Penalty Rate: ₹5,000Promoter Holding: 61.91%Market Capitalization: ₹12 CrTTM Revenue: ₹102 Cr
📅 Short termNegative sentiment is expected to persist as the company remains non-compliant; the risk of a 'Trade-for-Trade' category shift poses immediate liquidity risks.
📈 Long termThe long-term outlook is clouded by governance concerns; the company's ability to restore investor trust depends entirely on the findings of the forensic audit and the rectification of its books.
⚠ Risk flags
- Forensic audit initiated due to accounting discrepancies
- Regulatory non-compliance with SEBI LODR Regulation 33
- Potential freezing of promoter shareholding
- Risk of being moved to 'Z' category (Trade-for-Trade)
Key Highlights
NSE imposed a fine of ₹2,65,500 inclusive of GST for non-submission of FY26 results as of July 16, 2026.
Daily penalty of ₹5,000 continues to accrue for every day of non-compliance beyond the notice period.
Statutory auditors identified material gaps and discrepancies in the books of accounts for FY ended March 31, 2026.
A Forensic Auditor was appointed, and preliminary findings were presented to the Board on August 06, 2026.
NSE has issued a final reminder warning of freezing promoter holdings if compliance and fine payments are not completed.
👀 What to Watch
Investors should closely monitor the release of the final Forensic Audit report and the subsequent audited financial results to assess the severity of the accounting discrepancies. Watch for any NSE notification regarding the freezing of promoter shares or the shifting of the stock to the 'Z' category, which would severely impact liquidity.
Shanthala FMCG: Forensic Audit, NSE Non-Compliance, and HUL Contract Termination
Shanthala FMCG (Market Cap: ₹12 Cr) has disclosed three critical negative developments following its August 6, 2026 board meeting. The company is currently undergoing a forensic audit by GuruJana Consulting LLP and has received non-compliance notices from the NSE regarding financial result filings (Regulation 33). Additionally, the company announced the termination of its distributorship arrangement with Hindustan Unilever Limited (HUL), which is a significant blow to its trading-based business model that generated ₹102 Cr in TTM revenue.
Confidence: HIGH
What changedThe company is now under forensic investigation, faces exchange-level regulatory action for missing filings, and has lost its primary distributorship partner (HUL).
Why it mattersFor a micro-cap trading company, a forensic audit and the loss of a major principal like HUL are existential threats to the business model and listing status.
Market Capitalization: ₹12 CrTTM Revenue: ₹102 Cr12-Month Price Return: -50.7%Operating Profit Margin: 0.7%
📅 Short termExpect significant downward pressure and high volatility as the market reacts to the forensic audit and the loss of the HUL partnership.
📈 Long termThe long-term viability is highly uncertain given the forensic scrutiny and the loss of a major brand partnership in the FMCG trading space.
⚠ Risk flags
- Forensic audit (potential fraud/mismanagement)
- Regulatory non-compliance (NSE notices)
- Loss of major principal (HUL termination)
- Extremely thin operating margins (0.7%)
Key Highlights
Ongoing forensic audit being conducted by M/s. GuruJana Consulting LLP reviewed by the Board
Receipt of formal notices from NSE for non-compliance with SEBI Regulation 33 (Financial Results)
Termination of the distributorship arrangement with Hindustan Unilever Limited (HUL)
Company market capitalization is extremely low at ₹12 Cr relative to ₹102 Cr TTM revenue
Share price has already declined by 50.7% over the last 12 months
👀 What to Watch
Investors should closely monitor the findings of the forensic audit and the company's ability to file its pending financial results to avoid potential trading suspension. The loss of the HUL contract requires urgent clarity on how the company will replace this revenue stream.
Shanthala FMCG Appoints New Forensic Auditor Following Resignation of Previous Firm
Shanthala FMCG Products Limited has replaced its forensic auditor, M/s. Chaudhary Chaudhary & Co, with M/s. GuruJana Consulting LLP. The outgoing auditor resigned citing an inability to dedicate the required time to conclude the audit within the stipulated timeframe. This change occurs approximately seven weeks after the initial audit appointment on June 07, 2026. Given the company's small market capitalization of Rs 12 Cr and a 47.5% stock price decline over the last six months, the forensic audit outcome is a critical governance event.
Confidence: HIGH
What changedThe firm responsible for conducting the forensic audit of the company's books has been replaced mid-process due to the resignation of the previous auditor.
Why it mattersA forensic audit is a high-stakes investigation into financial records; a change in auditor can signal urgency or potential delays in resolving governance concerns that have likely contributed to the recent 47% share price drop.
Market Capitalization: Rs 12 Cr6-Month Price Return: -47.5%Original Audit Initiation Date: June 07, 2026TTM Revenue: Rs 102 Cr
📅 Short termThe change in auditor during an active forensic investigation is likely to maintain or increase negative sentiment and volatility in the stock.
📈 Long termThe structural integrity of the business depends entirely on the findings of this audit; until cleared, governance risks remain the primary driver of valuation.
⚠ Risk flags
- Forensic audit of books
- Auditor resignation during investigation
- Significant 12-month price erosion (-46.6%)
- Micro-cap liquidity risks
Key Highlights
Forensic audit originally initiated/disclosed on June 07, 2026
Outgoing auditor M/s. Chaudhary Chaudhary & Co resigned citing professional commitments
New auditor M/s. GuruJana Consulting LLP appointed on July 27, 2026, to ensure 'expeditious' completion
Company market capitalization stands at a micro-cap level of Rs 12 Cr
Stock price has declined by 47.5% over the preceding six-month period
👀 What to Watch
Investors should closely monitor the company's disclosures for the final forensic audit report and any subsequent regulatory actions or management clarifications regarding the specific scope of the investigation.
